Form D Raw Data - Electronic Filing Depository

EFDID: 369195EFD: Raw Data

Issuer: Nacuity Pharmaceuticals, Inc. (0001690279) - D/A

Accession: 0001690279-22-000001 () (EDGAR Files) (Form D)

Edgar Posted: Jan. 3, 2022
EFD Posted: Jan. 3, 2022

- < edgarSubmission >

< schemaVersion > X0708 </ schemaVersion >

< submissionType > D/A </ submissionType >

< testOrLive > LIVE </ testOrLive >

- < primaryIssuer >

< cik > 0001690279 </ cik >

< entityName > Nacuity Pharmaceuticals, Inc. </ entityName >

- < issuerAddress >

< street1 > FORT WORTH CLUB BLDG. </ street1 >

< street2 > 306 W. 7TH STREET, SUITE 310 </ street2 >

< city > FORT WORTH </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ issuerAddress >

< issuerPhoneNumber > 817-336-3000 </ issuerPhoneNumber >

< jurisdictionOfInc > DELAWARE </ jurisdictionOfInc >

- < issuerPreviousNameList >

< value > None </ value >

</ issuerPreviousNameList >

- < edgarPreviousNameList >

< value > None </ value >

</ edgarPreviousNameList >

< entityType > Corporation </ entityType >

- < yearOfInc >

< overFiveYears > true </ overFiveYears >

</ yearOfInc >

</ primaryIssuer >

- < relatedPersonsList >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Halden </ firstName >

< lastName > Conner </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification > President and Chief Executive Officer </ relationshipClarification >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > David </ firstName >

< lastName > Wohlberg </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification > Secretary </ relationshipClarification >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Gerald </ firstName >

< lastName > Cagle </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Robin </ firstName >

< lastName > Steel </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Benjamin </ firstName >

< lastName > Yerxa </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Charles </ firstName >

< lastName > Lieser </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification > Chief Financial Officer </ relationshipClarification >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Robert </ firstName >

< lastName > Ruffolo </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 306 West 7th Street </ street1 >

< street2 > Suite 310 </ street2 >

< city > Fort Worth </ city >

< stateOrCountry > TX </ stateOrCountry >

< stateOrCountryDescription > TEXAS </ stateOrCountryDescription >

< zipCode > 76102 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

</ relatedPersonsList >

- < offeringData >

- < industryGroup >

< industryGroupType > Biotechnology </ industryGroupType >

</ industryGroup >

- < issuerSize >

< revenueRange > Decline to Disclose </ revenueRange >

</ issuerSize >

- < federalExemptionsExclusions >

< item > 06b </ item >

</ federalExemptionsExclusions >

- < typeOfFiling >

- < newOrAmendment >

< isAmendment > true </ isAmendment >

< previousAccessionNumber > 0001690279-21-000003 </ previousAccessionNumber >

</ newOrAmendment >

- < dateOfFirstSale >

< value > 2021-03-16 </ value >

</ dateOfFirstSale >

</ typeOfFiling >

- < durationOfOffering >

< moreThanOneYear > false </ moreThanOneYear >

</ durationOfOffering >

- < typesOfSecuritiesOffered >

< isEquityType > true </ isEquityType >

< isOptionToAcquireType > true </ isOptionToAcquireType >

< isSecurityToBeAcquiredType > true </ isSecurityToBeAcquiredType >

< isOtherType > true </ isOtherType >

< descriptionOfOtherType > Units comprised of Convertible Preferred Shares plus Common Stock Purchase Warrants; Common Stock issued for Warrant conversion; Convertible Preferred Shares issued for exchange of Common Stock </ descriptionOfOtherType >

</ typesOfSecuritiesOffered >

- < businessCombinationTransaction >

< isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >

< clarificationOfResponse />

</ businessCombinationTransaction >

< minimumInvestmentAccepted > 10000 </ minimumInvestmentAccepted >

- < salesCompensationList >

- < recipient >

< recipientName > Maxim Group LLC </ recipientName >

< recipientCRDNumber > 120708 </ recipientCRDNumber >

< associatedBDName > Clifford Adam Teller </ associatedBDName >

< associatedBDCRDNumber > 4631188 </ associatedBDCRDNumber >

- < recipientAddress >

< street1 > 405 Lexington Avenue </ street1 >

< city > New York </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10174 </ zipCode >

</ recipientAddress >

- < statesOfSolicitationList >

< value > All States </ value >

</ statesOfSolicitationList >

< foreignSolicitation > false </ foreignSolicitation >

</ recipient >

</ salesCompensationList >

- < offeringSalesAmounts >

< totalOfferingAmount > 17400000 </ totalOfferingAmount >

< totalAmountSold > 11626000 </ totalAmountSold >

< totalRemaining > 5774000 </ totalRemaining >

< clarificationOfResponse />

</ offeringSalesAmounts >

- < investors >

< hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >

< totalNumberAlreadyInvested > 144 </ totalNumberAlreadyInvested >

</ investors >

- < salesCommissionsFindersFees >

- < salesCommissions >

< dollarAmount > 1444673 </ dollarAmount >

</ salesCommissions >

- < findersFees >

< dollarAmount > 0 </ dollarAmount >

</ findersFees >

< clarificationOfResponse > Commissions include warrants to purchase 716,949 shares of Common Stock at an exercise price of $0.01 per share. </ clarificationOfResponse >

</ salesCommissionsFindersFees >

- < useOfProceeds >

- < grossProceedsUsed >

< dollarAmount > 0 </ dollarAmount >

</ grossProceedsUsed >

< clarificationOfResponse />

</ useOfProceeds >

- < signatureBlock >

< authorizedRepresentative > false </ authorizedRepresentative >

- < signature >

< issuerName > Nacuity Pharmaceuticals, Inc. </ issuerName >

< signatureName > /s/ Halden Conner </ signatureName >

< nameOfSigner > Halden Conner </ nameOfSigner >

< signatureTitle > President and Chief Executive Officer </ signatureTitle >

< signatureDate > 2022-01-03 </ signatureDate >

</ signature >

</ signatureBlock >

</ offeringData >

</ edgarSubmission >